Correlation Between CapitaLand Investment and Lees Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both CapitaLand Investment and Lees Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CapitaLand Investment and Lees Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CapitaLand Investment Limited and Lees Pharmaceutical Holdings, you can compare the effects of market volatilities on CapitaLand Investment and Lees Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CapitaLand Investment with a short position of Lees Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of CapitaLand Investment and Lees Pharmaceutical.

Diversification Opportunities for CapitaLand Investment and Lees Pharmaceutical

0.19

Correlation Coefficient

CapitaLand Investment  Lees Pharmaceutical

Average diversification

The 3 months correlation between CapitaLand and Lees is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding CapitaLand Investment Limited and Lees Pharmaceutical Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lees Pharmaceutical and CapitaLand Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CapitaLand Investment Limited are associated (or correlated) with Lees Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lees Pharmaceutical has no effect on the direction of CapitaLand Investment i.e., CapitaLand Investment and Lees Pharmaceutical go up and down completely randomly.

Pair Corralation between CapitaLand Investment and Lees Pharmaceutical

If you would invest  182.00  in CapitaLand Investment Limited on September 27, 2024 and sell it today you would earn a total of  17.00  from holding CapitaLand Investment Limited or generate 9.34% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	4.76%
Values	Daily Returns

CapitaLand Investment Limited  vs.  Lees Pharmaceutical Holdings

CapitaLand Investment

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CapitaLand Investment Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Lees Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lees Pharmaceutical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Lees Pharmaceutical is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with CapitaLand Investment and Lees Pharmaceutical

The main advantage of trading using opposite CapitaLand Investment and Lees Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CapitaLand Investment position performs unexpectedly, Lees Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lees Pharmaceutical will offset losses from the drop in Lees Pharmaceutical's long position.

The idea behind CapitaLand Investment Limited and Lees Pharmaceutical Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.